COMMUNIQUÉS West-GlobeNewswire

Clover Health Appoints Joseph Oldakowski as Vice President of Finance and Controller
17/07/2025
WILMINGTON, Del., July 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”) , a physician enablement company bringing access to great healthcare to everyone on Medicare, today [...]
Health Catalyst to Announce Second Quarter 2025 Operating Results and Host Conference Call on Thursday, August 7, 2025
17/07/2025
SALT LAKE CITY, July 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its [...]
Milestone Scientific Commences Sales of CompuFlo® Epidural System at The Painless Center in Tenafly, New Jersey
17/07/2025
ROSELAND, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the [...]
BioNTech Announces Ryan Richardson to Step Down from the Management Board
17/07/2025
MAINZ, Germany, July 17, 2025 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that Ryan Richardson will step down as Chief Strategy Officer in the Management Board of BioNTech [...]
Neurogen Biomarking to present novel data on at-home p-tau 217 testing for Alzheimer’s disease at Alzheimer’s Association International Conference® 2025
17/07/2025
CHICAGO, July 17, 2025 (GLOBE NEWSWIRE) -- Neurogen Biomarking will present novel data on at-home p-tau 217 testing for Alzheimer’s disease at the upcoming Alzheimer’s Association International Conference® (AAIC) in [...]
Vor Bio Appoints Qing Zuraw, M.D. as Chief Development Officer
17/07/2025
Dr. Zuraw led clinical development of telitacicept across MG, Sjögren’s, SLE, and RA at RemeGen, resulting in multiple regulatory approvals in China ; brings deep U.S. and global development experience to support Vor [...]
Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock
17/07/2025
Led by Strategic Industry Partner and Select Institutional Investors Proceeds Strengthen Balance Sheet and Support Commercialization of Innovation Strategy ST. LOUIS, July 17, 2025 (GLOBE NEWSWIRE) -- Stereotaxis, Inc [...]
Actuate Therapeutics Advances Clinical Program in Ewing Sarcoma After Positive Phase 1 Trial Demonstrates Complete and Partial Responses in Difficult-to-Treat Pediatric Sarcomas
17/07/2025
- Announces Completion of Phase 1 Study of Elraglusib in Pediatric Patients - Prolonged and Durable Complete Responses (CRs) Observed in Two of Ten Refractory Ewing Sarcoma Patients - Two Additional Patients Had Durable [...]
Tria Federal Expands VA Partnership with $174M Software Engineering & Development Award
17/07/2025
ARLINGTON, Va., July 17, 2025 (GLOBE NEWSWIRE) -- Tria Federal has received a $174 million contract award to provide expanded software engineering and development services to the Department of Veterans Affairs’ (VA) [...]
Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies
17/07/2025
SEATTLE, July 17, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 AI Labs, LLC, an innovative subsidiary of Fifty 1 Labs, Inc. ( OTC: FITY ), is thrilled to announce a strategic partnership with an intent to acquire BioSpark [...]
RadNet’s Wholly-Owned Subsidiary, DeepHealth, Completes Acquisition of iCAD
17/07/2025
Acquisition contributes iCAD's commercial, technology, and regulatory capabilities The acquisition positions DeepHealth with an industry-leading suite of AI-powered breast cancer image interpretation and workflow [...]
OKYO Pharma Receives $1.9 Million in Non-Dilutive Funding to Accelerate Development of Urcosimod for Neuropathic Corneal Pain
17/07/2025
LONDON and NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO ), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an [...]
Connect Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
17/07/2025
SAN DIEGO, July 17, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care for the [...]
Adventure Awaits: Make-A-Wish® Central and Northern Florida Makes Jeremy’s Dream Come True with a Thrilling Mexican Sport Fishing Adventure
17/07/2025
Family to Embark on an Unforgettable Trip, Courtesy of Stan and Naomi Loomis ORLANDO, Fla., July 17, 2025 (GLOBE NEWSWIRE) -- Make-A-Wish® Central and Northern Florida , in collaboration with Stan and Naomi Loomis, co- [...]
Philips Launches ECG AI Marketplace to Enhance Early Cardiac Diagnosis
17/07/2025
July 17, 2025 Anumana's FDA-cleared LEF algorithm becomes first certified third-party solution available through Philips’ ECG ecosystem CAMBRIDGE, Mass. — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health [...]
Dogecoin Cash Inc. (OTCQB: DOGP) Reports Preparation of Provisional Patent Application for “Dogecoin Protocol” Architecture
17/07/2025
Company evaluating technical architecture intended to support interoperability and programmability for Dogecoin Mesquite, NV, July 17, 2025 (GLOBE NEWSWIRE) -- Dogecoin Cash Inc. (OTCQB: DOGP) today reported that it is [...]
Ascentage Pharma Announces Closing of Placement Shares in Top-Up Placement
17/07/2025
ROCKVILLE, Md. and SUZHOU, China, July 17, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“ Ascentage Pharma ” or the “ Company ”), a global biopharmaceutical company dedicated [...]
Immuron - FY25 global sales exceed projection, up 49% on prior year
17/07/2025
Sales Highlights (unaudited): Global Annual sales AUD$7.3 million up 49% on prior year June 2025 Quarter AUD$2.0 million up 55% on prior year Australia Annual sales AUD$5.2 million up 40% on prior year June 2025 Quarter [...]
Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025
17/07/2025
Company to participate in investor conferences in July and August VANCOUVER, British Columbia, July 17, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse [...]

Pages